Docetaxel (precursor) liposome（Jinling）
多西他赛（前体）脂质体（金陵药业）
Report date: 2022/11/24 15:37:52
Base Information
Drug NameDocetaxel (precursor) liposome（Jinling）
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesJinling Pharmaceutical Co Ltd Technology Center
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksN/A